IMPORTANT MESSAGE REGARDING COVID-19

Author Archive

Private Equity Firm and Co-Defendants to Pay $25 Million to Resolve Whistleblower’s Medicaid Fraud Claims in Qui Tam Settlement

Waters Kraus & Paul, national plaintiffs firm

Private Equity Firm and Co-Defendants to Pay $25 Million to Resolve Whistleblower’s Medicaid Fraud Claims in Qui Tam Settlement

Whistleblower to receive maximum award for contributions to the case alleging mental health provider chain billed Medicaid for services provided by unqualified and unsupervised providers

BOSTON –  Private equity firm H.I.G. Capital, LLC and its subsidiary, H.I.G. Growth Partners, LLC (“H.I.G.”), together with Peter J. Scanlon and Kevin P. Sheehan, have  agreed to pay $25 million...

The Right to Vote: Fight. Defend. Win.

The Right to Vote: Fight. Defend. Win.

Your vote is your voice — and Waters & Kraus is fighting to protect it.

Voter suppression has a long and ugly history in the United States, from poll taxes and literacy tests to outright bans on certain groups from voting. While voter disenfranchisement today may not be quite as overt, we still have to work hard to protect voter’s rights.

Waters...

Texas Votes 2020: What You Need to Know

Texas Votes 2020: What You Need to Know

Make your voice heard — have a plan when you go to the polls to ensure a successful voting experience.

We work hard to fight for the rights of our clients, and that extends to the ability to freely cast our votes. Your vote is your voice — and the very bedrock of our democracy. But it can be challenging for some to vote in Texas. These frequently asked...

Coverage of Fluoride Lawsuit in California

Waters Kraus & Paul

Coverage of Fluoride Lawsuit in California

Waters Kraus & Paul represents plaintiffs in a California fluoride case against the U.S. EPA in one of the first remote trials in the country.

Waters Kraus & Paul attorney, Michael Connett and firm partner C. Andrew Waters, wrapped up a civil trial last week representing several plaintiffs against the U.S. Environmental Protection Agency (EPA) for a...

New IVC Filter Clinical Trial to Study Potential Risks

New IVC Filter Clinical Trial to Study Potential Risks

January 21, 2016 – Patients are now being enrolled in a new study to assess the effectiveness and safety of inferior vena cava (IVC) filters — small medical devices implanted in the body to stop blood clots from reaching the heart or lungs. The five-year-long study will involve 2,100 patients at 60 medical sites around the country. PRESERVE (Predicting the Safety and Effectiveness of...

Toxic Exposure to Commonplace Household Products

Toxic Exposure to Commonplace Household Products

January 19, 2016 – When people think about toxic exposure to dangerous substances, images of Love Canal or asbestos remediation sites may come to mind. Most people are simply not aware that many commonplace household products can cause birth defects, genital deformities and cancer, including breast and prostate cancer. According to the International Federation of Gynecology and Obstetrics,...

Surgeons Question Stated Risk from Power Morcellators

Surgeons Question Stated Risk from Power Morcellators

January 14, 2016 – The U.S. Food and Drug Administration is receiving push-back on its 2014 warning about the threat to women from the use of power morcellators during gynecological procedures. A group of gynecologists from respected universities has asked the FDA to alter its position concerning the potentially dangerous medical devices.

Surgeons Ask FDA to Alter its Stance Concerning...

Less Radical Mesothelioma Surgery More Beneficial

Less Radical Mesothelioma Surgery More Beneficial

A mesothelioma expert with Mount Sinai in New York agrees with the finding of a recent Turkish study concerning the benefits of mesothelioma surgery. According to thoracic surgeon and researcher Raja Flores, MD, patients undergoing the less radical pleurectomy and decortication (PD) have better outcomes than those treated with extrapleural pneumonectomy (EPP).

Turkish Study of 72...

UDI Pilot Project Receives Additional FDA Funding

UDI Pilot Project Receives Additional FDA Funding

Five years ago, Mercy Hospital in Springfield, Missouri began a Unique Device Identifier (UDI) pilot project — a program to track implanted medical devices. The project has financial backing from the U.S. Food and Drug Administration (FDA). With a new grant from the FDA, Mercy Hospital reportedly is set to receive up to $5.2 million in the next three years. The additional funding will allow...

Vaginal Mesh Manufacturer Sets Aside $445 Million for U.S. Lawsuits

Vaginal Mesh Manufacturer Sets Aside $445 Million for U.S. Lawsuits

Coloplast, the Danish medical device manufacturer, has set aside $445 million to pay U.S. women injured by the company’s transvaginal surgical mesh products. After making the announcement, Coloplast’s financial results for the year reportedly fell 62 percent.

Danish Transvaginal Mesh Manufacturer Predicts that Some Lawsuits Against it are Likely to Go to Trial

Vaginal mesh is a...

What are my chances?

That’s the first question everyone asks. The truth is it’s impossible to know. But we can tell you this. Waters Kraus & Paul has what it takes to fight against big corporate interests and win. That’s why we’ve taken more mesothelioma trials to verdict than any other firm. And that’s why we’ve recovered more than $1.3 billion for clients like you. Do you think you have a case? Contact us now to speak with an attorney.

Call 800.226.9880